Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (111-120 of 298) with videos related to

Pageof 30
Sort By:
Journal of Pharmaceutical Sciences|May 25, 2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studiesSuzanne M Caliph, Natalie L Trevaskis, William N Charman, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipidsAnn Marie Kaukonen, Ben J Boyd, William N Charman, et al.
Journal of Pharmaceutical Sciences|December 25, 2004
Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drugGreg A Kossena, William N Charman, Ben J Boyd, et al.
Pharmaceutical Research|July 17, 2010
The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profilesNatalie L Trevaskis, Ravi M Shanker, William N Charman, et al.
Journal of Medicinal Chemistry|June 7, 2008
Characterization of the drug binding specificity of rat liver fatty acid binding proteinSara Chuang, Tony Velkov, James Horne, et al.
Molecular Pharmaceutics|December 22, 2016
Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption PeriodsMatthew F Crum, Natalie L Trevaskis, Colin W Pouton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2014
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drugOrlagh M Feeney, Hywel D Williams, Colin W Pouton, et al.
The Journal of Pharmacy and Pharmacology|July 20, 2010
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Molecular Pharmaceutics|April 17, 2018
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based FormulationEstelle J A Suys, David K Chalmers, Colin W Pouton, et al.
Letters in Applied Microbiology|April 20, 2006
Comparison of agar plate and real-time PCR on enumeration of Lactobacillus, Clostridium perfringens and total anaerobic bacteria in dog faecesC J Fu, J N Carter, Y Li, et al.
Pageof 30

Showing results (111-120 of 298) with videos related to

Sort By:
Pageof 30
Journal of Pharmaceutical Sciences|May 25, 2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studiesSuzanne M Caliph, Natalie L Trevaskis, William N Charman, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipidsAnn Marie Kaukonen, Ben J Boyd, William N Charman, et al.
Journal of Pharmaceutical Sciences|December 25, 2004
Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drugGreg A Kossena, William N Charman, Ben J Boyd, et al.
Pharmaceutical Research|July 17, 2010
The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profilesNatalie L Trevaskis, Ravi M Shanker, William N Charman, et al.
Journal of Medicinal Chemistry|June 7, 2008
Characterization of the drug binding specificity of rat liver fatty acid binding proteinSara Chuang, Tony Velkov, James Horne, et al.
Molecular Pharmaceutics|December 22, 2016
Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption PeriodsMatthew F Crum, Natalie L Trevaskis, Colin W Pouton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2014
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drugOrlagh M Feeney, Hywel D Williams, Colin W Pouton, et al.
The Journal of Pharmacy and Pharmacology|July 20, 2010
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Molecular Pharmaceutics|April 17, 2018
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based FormulationEstelle J A Suys, David K Chalmers, Colin W Pouton, et al.
Letters in Applied Microbiology|April 20, 2006
Comparison of agar plate and real-time PCR on enumeration of Lactobacillus, Clostridium perfringens and total anaerobic bacteria in dog faecesC J Fu, J N Carter, Y Li, et al.
Pageof 30